An increased transforming growth factor β receptor type I:Type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase‐deficient transforming growth factor β receptor type II in scleroderma
Open Access
- 6 May 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (5), 1566-1577
- https://doi.org/10.1002/art.20225
Abstract
Objective Aberrant transforming growth factor β (TGFβ) signaling has been implicated in the pathogenesis of scleroderma (systemic sclerosis [SSc]), but the contribution of specific components in this pathway to SSc fibroblast phenotype remains unclear. This study was undertaken to delineate the role of TGFβ receptor type I (TGFβRI) and TGFβRII in collagen overexpression by SSc fibroblasts. Methods Primary dermal fibroblasts from SSc patients and healthy adults were studied (n = 10 matched pairs). Adenoviral vectors were generated for TGFβRI (AdTGFβRI), TGFβRII (AdTGFβRII), and kinase-deficient TGFβRII (AdΔkRII). TGFβRI basal protein levels were analyzed by 35S-methionine labeling/immunoprecipitation and immunohistochemistry. Type I collagen and TGFβRII basal protein levels were analyzed by Western blot and newly secreted collagen by 3H-proline incorporation assay. Results Analysis of endogenous TGFβRI and TGFβRII protein levels revealed that SSc TGFβRI levels were increased 1.7-fold (P = 0.008; n = 7) compared with levels in healthy controls, while TGFβRII levels were decreased by 30% (P = 0.03; n = 7). This increased TGFβRI:TGFβRII ratio correlated with SSc collagen overexpression. To determine the consequences of altered TGFβRI:TGFβRII ratio on collagen expression, healthy fibroblasts were transduced with AdTGFβRI or AdTGFβRII. Forced expression of TGFβRI in the range corresponding to elevated SSc TGFβRI levels increased basal collagen expression in a dose-dependent manner, while similar TGFβRII overexpression had no effect, although transduction of fibroblasts at higher multiplicities of infection led to a marked reduction of basal collagen levels. Blockade of TGFβ signaling via AdΔkRII resulted in ∼50% inhibition of basal collagen levels in healthy fibroblasts and in 5 of 9 SSc cell lines. A subset of SSc fibroblasts (4 of 9 cell lines) was resistant to this treatment. SSc fibroblasts with the highest levels of TGFβRI were the least responsive to collagen inhibition via ΔkRII. Conclusion This study indicates that an increased TGFβRI:TGFβRII ratio may underlie aberrant TGFβ signaling in SSc and contribute to elevated basal collagen production, which is insensitive to TGFβ signaling blockade via ΔkRII.Keywords
This publication has 27 references indexed in Scilit:
- Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblastsArthritis & Rheumatism, 2003
- Altered negative regulation of transforming growth factor β signaling in scleroderma: Potential involvement of SMURF2 in diseaseArthritis & Rheumatism, 2003
- Fibroblast-specific Expression of a Kinase-deficient Type II Transforming Growth Factor β (TGFβ) Receptor Leads to Paradoxical Activation of TGFβ Signaling Pathways with Fibrosis in Transgenic MiceJournal of Biological Chemistry, 2003
- Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrestOncogene, 2003
- Epidermal growth factor up‐regulates expression of transforming growth factor β receptor type II in human dermal fibroblasts by phosphoinositide 3‐kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblastsArthritis & Rheumatism, 2003
- Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblastsArthritis & Rheumatism, 2003
- Molecular aspects of sclerodermaFrontiers in Bioscience-Landmark, 2002
- Differential regulation of transforming growth factor-beta receptors type I and II by platelet-derived growth factor in human dermal fibroblastsBritish Journal of Dermatology, 2001
- Adenoviral vector which delivers FasL–GFP fusion protein regulated by the tet-inducible expression systemGene Therapy, 2000
- Role of Transforming Growth Factor β Type Ii Receptor in Hepatic Fibrosis: Studies of Human Chronic Hepatitis C and Experimental Fibrosis in RatsHepatology, 1999